Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
Analyst Downgrade
|
Mid-range Performer
2171.5000
13.40
(
0.62
%)
NSE
Aug 28, 2026
15:31 PM
Volume:
347.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
07 Aug 2025
Analyst Downgrade
2171.50
0.62%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2400
Target
Axis Direct
We recommend a BUY rating with a target price of Rs 2,500/share.
Deven Choksey decreased Accumulate price target of Lupin Ltd. to 2444.0 on 10 Aug, 2026.
More from Lupin Ltd.
Recommended
Market trades flat, Delhivery reportedly raises shipping charges for D2C brands
Trendlyne Marketwatch |
28 Aug 2026, 03:35PM
From weak rains to rural spending: India’s next monsoon test
The Baseline |
27 Aug 2026, 06:43PM
Lupin expects normalization by September quarter
|
17 Apr 2020